Home > Income Statement > ALEMBIC

ALEMBIC
Revenue

    Back to Income Statement
ALEMBIC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ALEMBIC
Please provide your vote to see the results

ALEMBIC Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹222 Cr₹157 Cr₹127 Cr₹78 Cr₹74 Cr

What is the latest Revenue of ALEMBIC ?

The latest Revenue ratio of ALEMBIC is ₹222 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹222 Cr
Mar2024₹157 Cr
Mar2023₹127 Cr
Mar2022₹78 Cr
Mar2021₹74 Cr

How is Revenue of ALEMBIC Trending?

Years Revenue % Change
Mar2025 ₹222 Cr
40.89
Mar2024 ₹157 Cr
23.77
Mar2023 ₹127 Cr
62.68
Mar2022 ₹78 Cr
6.40
Mar2021 ₹74 Cr -

Compare Revenue of peers of ALEMBIC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALEMBIC ₹2,381.8 Cr -0.8% -7.2% -21.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹381,326.0 Cr -2.8% -7.5% -12.2% Stock Analytics
DIVIS LABORATORIES ₹160,299.0 Cr -0.6% -5.5% 6.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹132,821.0 Cr -2.5% 3.5% 21.1% Stock Analytics
CIPLA ₹106,655.0 Cr -3.7% -11.7% -8.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,861.0 Cr -0.7% -4.7% -5.1% Stock Analytics


ALEMBIC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ALEMBIC

-0.8%

-7.2%

-21.3%

SENSEX

0.8%

-2.9%

8.1%


You may also like the below Video Courses